DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of 155 biotech and pharma professionals from across the US and Europe focusing on multi-indication cardiometabolic R&D for therapies targeting obesity and its comorbidities. Multi-indication studies are clinical trials that ...
ICON Public Limited Company (NASDAQ:ICLR ) Q1 2025 Earnings Call Transcript May 1, 2025 8:00 AM ET Company Participants Kate Haven - Vice President, Investor Relations Steve Cutler - Chief Executive Officer Nigel Clerkin - Chief Financial Officer Barry Balfe - Chief Operating Officer Conference Call Participants Ahmed Muhammad - Leerink Partners Patrick Donnelly - Citi David Windley - Jefferies...
The relentless bull run led by high-flying growth stocks is no longer here, and 2025 has brought a significant shift in the market landscape, with the S&P 500 now in correction territory.
LOS ANGELES , April 10, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against ICON plc ("ICON" or the "Company") (NASDAQ: ICLR). IF YOU SUFFERED A LOSS ON YOUR ICON INVESTMENTS, CLICK HERE BEFORE APRIL 11, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What I...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.